Bellevue Group’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $333K | Hold |
1,100
| – | – | 0.01% | 114 |
|
2025
Q1 | $364K | Hold |
1,100
| – | – | 0.01% | 123 |
|
2024
Q4 | $339K | Hold |
1,100
| – | – | 0.01% | 132 |
|
2024
Q3 | $233K | Hold |
1,100
| – | – | ﹤0.01% | 142 |
|
2024
Q2 | $308K | Buy |
1,100
+40
| +4% | +$11.2K | 0.01% | 140 |
|
2024
Q1 | $283K | Buy |
+1,060
| New | +$283K | ﹤0.01% | 146 |
|